Frédéric Pène

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study

Alexandra Rousseau, Elie Azoulay, Paul Coppo, 2016, American journal of hematology.

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Nicolas Carlier, Aurélien Corneau, Nicolas Roche, 2020, Science.